Table 2.
Construct | Linkage/Production method | PTD | Cell lines | Reference |
Fab | Conjugate | HIV1-TAT(37–62) | A431 breast carcinoma cells | Anderson 1993139 |
F(ab′)2 | Conjugate | HIV1 TAT(37–72) | Bovine chromaffin cells | Stein 1999142 |
whole IgG | Conjugate | KGEGAAVLLPVLLAAPG (“MTS“) | NIH 3T3 cells | Zhao 2001140 |
whole IgG | Conjugate | R68 | HeLa cells | Chen and Erlanger 2002143 |
MCF-7 cells | ||||
SK-BR-3 cells | ||||
murine lung enthothelial line | ||||
NIH 3T3 cells | ||||
scFv | Conjugate | HIV1 TAT (44–57) | HEK293 mice (injection) | Niesner 2002141 |
mAbs, pAbs | Conjugate | KGEGAAVLLPVLLAAPG (“MTS“) | Human lymphoma T cells | Zhao 2003144 |
scFv | Genetic fusion, C-terminal | HIV1 TAT(47–57) YGRKKRRQRRR | BMMC, RBL, MCF7 | Cohen-Saidon 2003145 |
scFv, radiolabeled | Genetic fusion, 5′-terminal of scFv, produced as inclusion body | HIV1 TAT(47–57) YGRKKRRQRRR | Mice | Nakajima 2004146 |
mAb | Conjugate | HIV1 TAT(47–57) YGRKKRRQRRR | MIN6 β cells | Ohara-Imaizumi 2004147 |
scFv | Fusion | MTS | 293T, BT-474 and PyVmT cells | Shin 2005148 |
Fab radiolabeled | Conjugate | HIV1 Tat protein (positions 48–60) | HeLa, rats | Kameyama 2006149 |
Antennapedia (positions 43–58) | ||||
HIV1 Rev protein (positions 34–50) | ||||
Fab-Rev radiolabeled | Conjugate | HIV1 REV peptide (positions 34–50) (TRQAR RNRRR RWRER QRGC) | HeLa, rats | Kameyama 2006150 |
IgG | Conjugate | R68 | NIH 3T3 | Chen 2006151 |
Scfv | Genetic fusion, produced as inclusion body | HIV1 TAT(47–57) | Jurkat T cells | Theisen 2006152 |
YGRKKRRQRRR | ||||
Fab radiolabeled | Conjugate | TAT (GRKKRRQRRRPPQ-C-amide), REV (TRQARRNRRRRWRERQR-GC-amide) and ANP (RQIKIWFQNRRMKWKK-GC-amide) | HeLa | Kameyama 2007153 |
mAb | Conjugate | GRKKRRQRRRPPQGYGC | MDA-MB-468 | Hu 2007154 |
scFv | Antennapedia genetic fusion, C-terminal, immunoaffinity purification | FlRQIKIWFQNRRMKWKK | HCT-116, MRC-5 | Avignolo 2008155 |
scFv | Genetic fusion | Penetratin | MDCK cells | Poungpair 2010156 |
Fab, fragment antigen-binding; mAbs, monoclonal antibodies; MTS, membrane transport sequence; pAbs, polyclonal antibodies; PTD, protein transduction domain; scFv, single chain fragment variable.